College of Health and Biomedicine, Victoria University, Melbourne, Victoria, Australia.
Brain Behav. 2018 Dec;8(12):e01102. doi: 10.1002/brb3.1102. Epub 2018 Oct 23.
In Prader-Willi syndrome (PWS), nonprotein coding small nucleolar (sno) RNAs are involved in the paternally deleted region of chromosome 15q11.2-q13, which is believed to cause the hyperphagic phenotype of PWS. Central to this is SnoRNA116. The supplement Caralluma fimbriata extract (CFE) has been shown to decrease appetite behavior in some individuals with PWS. We therefore investigated the mechanism underpinning the effect of CFE on food intake in the Snord116del mouse. Experiments utilized appetite stimulants which included a 5-hydroxytryptamine (5-HT) 2c receptor antagonist (SB242084), as the 5-HT2cR is implicated in central signaling of satiety.
After 9-week chronic CFE treatment (33 mg or 100 mg kg day ) or placebo, the 14-week-old Snord116del (SNO) and wild-type mice (n = 72) were rotated through intraperitoneal injections of (a) isotonic saline; (b) 400 mg/kg of 2-deoxyglucose (2DG) (glucose deprivation); (c) 100 mglkg beta-mercaptoacetate (MA), fatty acid signaling; and (d) SB242084 (a selective 5HT2cR antagonist), with 5 days between reagents. Assessments of food intake were from baseline to 4 hr, followed by immunohistochemistry of neural activity utilizing c-Fos, neuropeptide Y, and alpha-melanocyte-stimulating hormone within hypothalamic appetite pathways.
Caralluma fimbriata extract administration decreased food intake more strongly in the SNO100CFE group with significantly stimulated food intake demonstrated during coadministration with SB242084. Though stimulatory deprivation was expected to stimulate food intake, 2DG and MA resulted in lower intake in the snord116del mice compared to the WT animals (p = <0.001). Immunohistochemical mapping of hypothalamic neural activity was consistent with the behavioral studies.
This study identifies a role for the 5-HT2cR in CFE-induced appetite suppression and significant stimulatory feeding disruptions in the snord116del mouse model.
在普拉德-威利综合征(PWS)中,非蛋白编码的小核仁(sno)RNA 参与 15q11.2-q13 染色体的父系缺失区域,这被认为是导致 PWS 暴食表型的原因。其中核心是 snoRNA116。补充卡鲁玛菲因布拉里提取物(CFE)已被证明可减少部分 PWS 患者的食欲行为。因此,我们研究了 CFE 对 Snord116del 小鼠摄食的作用机制。实验利用食欲刺激剂,包括 5-羟色胺(5-HT)2c 受体拮抗剂(SB242084),因为 5-HT2cR 参与了饱腹感的中枢信号传递。
在接受 9 周慢性 CFE 治疗(33mg 或 100mg/kg/天)或安慰剂后,14 周龄的 Snord116del(SNO)和野生型小鼠(n=72)轮流接受腹腔内注射(a)等渗盐水;(b)400mg/kg 2-脱氧葡萄糖(2DG)(葡萄糖剥夺);(c)100mglkg β-巯基乙酸(MA),脂肪酸信号;和(d)SB242084(一种选择性 5-HT2cR 拮抗剂),每 5 天更换一次试剂。从基线到 4 小时评估食物摄入量,然后利用 c-Fos、神经肽 Y 和 α-促黑素细胞刺激素在下丘脑食欲通路中的免疫组织化学方法评估神经活动。
CFE 给药在 SNO100CFE 组中更强烈地降低了食物摄入量,并且在与 SB242084 联合给药时表现出明显的刺激食物摄入。尽管预期剥夺刺激会刺激食物摄入,但与 WT 动物相比,2DG 和 MA 导致 snord116del 小鼠的摄入量降低(p<0.001)。下丘脑神经活动的免疫组织化学图谱与行为研究一致。
本研究确定了 5-HT2cR 在 CFE 诱导的食欲抑制和 snord116del 小鼠模型中显著的刺激性摄食障碍中的作用。